Go Pro

XOMA (XOMAO) 10K Form and Latest SEC Filings 2026

XOMA logo
$25.00 0.00 (0.00%)
As of 09/25/2026

Latest XOMA SEC Filings & Recent Activity

XOMA (NASDAQ:XOMAO) has submitted 420+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in XOMA's financial statements. The most recent filing was a Form SCHEDULE 13G/A submitted on August 7, 2026.

Form 4
XOMA Royalty Corp Reports Ownership Change on Jul. 16, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
XOMA Files Quarterly Report on May. 12, 2026

The 10-Q contains XOMA's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

XOMA SEC Filing History

Browse XOMA's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/07/2026 4:28 PM
MORGAN STANLEY (895421) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
08/07/2026 4:32 PM
MORGAN STANLEY (895421) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
08/07/2026 10:07 AM
FMR LLC (315066) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
08/06/2026 9:48 AM
FMR LLC (315066) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
07/31/2026 9:47 AM
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
07/30/2026 10:18 AM
BlackRock, Inc. (2012383) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
07/20/2026 3:40 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:22 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:25 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:26 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:28 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:29 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:29 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:30 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:31 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:34 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:35 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:35 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:36 PM
XOMA (791908) Filer
Form S-8 POS
07/20/2026 3:16 PM
XOMA (791908) Filer
Form POS AM
07/20/2026 3:19 PM
XOMA (791908) Filer
Form S-8 POS
07/16/2026 4:00 PM
BIOTECHNOLOGY VALUE FUND L P (918923) Filed by
XOMA (791908) Subject
Form SCHEDULE 13D/A
07/16/2026 4:02 PM
BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting
BIOTECHNOLOGY VALUE FUND L P (918923) Reporting
Biotechnology Value Trading Fund OS LP (1660683) Reporting
BVF GP HOLDINGS LLC (1803809) Reporting
BVF I GP LLC (1803805) Reporting
BVF II GP LLC (1803806) Reporting
BVF INC/IL (1056807) Reporting
BVF PARTNERS L P/IL (1055947) Reporting
BVF Partners OS Ltd. (1660684) Reporting
LAMPERT MARK N (1233840) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2026 7:31 AM
Nasdaq Stock Market LLC (1354457) Filed by
XOMA (791908) Subject
Form 25-NSE
07/15/2026 9:39 AM
Nasdaq Stock Market LLC (1354457) Filed by
XOMA (791908) Subject
Form 25-NSE
07/14/2026 8:45 PM
Franklin Heather L (1436658) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
Trigilio Jeffrey (1838671) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
PERRY MATTHEW D (1454337) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
Sitko Bradley (1959809) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
Hernday Natasha (1780547) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
Hughes Owen (1575933) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
WYSZOMIERSKI JACK L (1023225) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
Kosacz Barbara (1763316) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
LIMBER JOSEPH M (1216023) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:45 PM
Montano Maricel Perea (2076299) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:10 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2026 4:22 PM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2026 4:24 PM
XOMA (791908) Filer
Form DEFA14A
06/10/2026 4:19 PM
XOMA (791908) Filer
Form DEFM14A
05/26/2026 5:07 PM
Kosacz Barbara (1763316) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 5:07 PM
Franklin Heather L (1436658) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
05/26/2026 5:08 PM
PERRY MATTHEW D (1454337) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 5:08 PM
Hernday Natasha (1780547) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 5:08 PM
LIMBER JOSEPH M (1216023) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 5:08 PM
WYSZOMIERSKI JACK L (1023225) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 10:28 AM
XOMA (791908) Subject
Form 425
05/22/2026 5:01 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2026 4:26 PM
BIOTECHNOLOGY VALUE FUND L P (918923) Filed by
XOMA (791908) Subject
Form SCHEDULE 13D/A
05/18/2026 4:29 PM
BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting
BIOTECHNOLOGY VALUE FUND L P (918923) Reporting
Biotechnology Value Trading Fund OS LP (1660683) Reporting
BVF GP HOLDINGS LLC (1803809) Reporting
BVF I GP LLC (1803805) Reporting
BVF II GP LLC (1803806) Reporting
BVF INC/IL (1056807) Reporting
BVF PARTNERS L P/IL (1055947) Reporting
BVF Partners OS Ltd. (1660684) Reporting
LAMPERT MARK N (1233840) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 8:11 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2026 8:13 AM
XOMA (791908) Filer
Form DEFA14A
05/15/2026 8:03 AM
Woodline Partners LP (1784547) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G
05/12/2026 3:06 PM
XOMA (791908) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2026 8:15 PM
LIGAND PHARMACEUTICALS INC (886163) Filed by
XOMA (791908) Subject
Form SCHEDULE 13D
04/30/2026 1:38 PM
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G
04/29/2026 4:43 PM
BIOTECHNOLOGY VALUE FUND L P (918923) Filed by
XOMA (791908) Subject
Form SCHEDULE 13D/A
04/27/2026 6:37 PM
LIGAND PHARMACEUTICALS INC (886163) Filer
XOMA (791908) Filer
Form DEFA14A
04/27/2026 3:12 PM
BlackRock, Inc. (2012383) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G
04/27/2026 3:01 PM
XOMA (791908) Filer
Form 8-K/A
04/27/2026 7:16 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2026 7:19 AM
XOMA (791908) Filer
Form DEFA14A
04/22/2026 3:30 PM
Sitko Bradley (1959809) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2026 3:30 PM
Hughes Owen (1575933) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2026 3:30 PM
Montano Maricel Perea (2076299) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2026 3:30 PM
Trigilio Jeffrey (1838671) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2026 5:13 PM
Trigilio Jeffrey (1838671) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2026 3:30 PM
LIMBER JOSEPH M (1216023) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 4:34 PM
XOMA (791908) Filer
Form DEFA14A
03/30/2026 4:35 PM
XOMA (791908) Filer
Form ARS
03/27/2026 1:14 PM
VANGUARD GROUP INC (102909) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
03/26/2026 3:30 PM
WYSZOMIERSKI JACK L (1023225) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2026 5:45 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2026 3:38 PM
Hughes Owen (1575933) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:09 PM
Montano Maricel Perea (2076299) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:09 PM
Trigilio Jeffrey (1838671) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:09 PM
Sitko Bradley (1959809) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 9:05 AM
FMR LLC (315066) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
03/02/2026 5:04 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2026 1:36 PM
MORGAN STANLEY (895421) Filed by
XOMA (791908) Subject
Form SCHEDULE 13G/A
02/09/2026 3:19 PM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2026 4:14 PM
Generation Bio Co. (1733294) Subject
XOMA (791908) Filed by
Form SC TO-T/A
01/15/2026 3:25 PM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2026 3:30 PM
Trigilio Jeffrey (1838671) Reporting
XOMA (791908) Issuer
Form 3
Initial statement of beneficial ownership of securities  
01/14/2026 3:35 PM
Trigilio Jeffrey (1838671) Reporting
XOMA (791908) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 6:58 AM
Generation Bio Co. (1733294) Subject
XOMA (791908) Filed by
Form SC TO-T/A
01/12/2026 6:00 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 3:05 PM
Generation Bio Co. (1733294) Subject
XOMA (791908) Filed by
Form SC TO-T
12/15/2025 7:36 PM
Generation Bio Co. (1733294) Subject
XOMA (791908) Filed by
Form SC TO-C
12/05/2025 8:15 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2025 6:50 AM
LAVA Therapeutics NV (1840748) Subject
XOMA (791908) Filed by
Form SC TO-T/A
11/21/2025 7:03 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
11/13/2025 6:16 AM
LAVA Therapeutics NV (1840748) Subject
XOMA (791908) Filed by
Form SC TO-T/A
11/12/2025 6:46 AM
XOMA (791908) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2025 6:46 AM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2025 11:22 AM
LAVA Therapeutics NV (1840748) Subject
XOMA (791908) Filed by
Form SC TO-T/A
10/03/2025 4:24 PM
XOMA (791908) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2025 4:00 PM
XOMA (791908) Filer
Form 424B5
10/03/2025 4:03 PM
XOMA (791908) Filer
Form 424B5
10/02/2025 3:35 PM
LAVA Therapeutics NV (1840748) Subject
XOMA (791908) Filed by
Form SC TO-T/A
(Data available from 1/1/2016 forward)

XOMA SEC Filings - Frequently Asked Questions

XOMA (XOMAO) has submitted 420+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form SCHEDULE 13G/A submitted on August 7, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:XOMAO are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/7/2026. New filings are added as they're published.
From Our Partners